Introduction
============

The CORTICUS trial doubts the value of hydrocortisone replacement for final outcome of septic shock \[[@B1]\]. We hypothesized that the time of starting hydrocortisone may impact on the final outcome.

Methods
=======

Retrospective analysis was made of prospectively collected data for 41 patients with septic shock (ACCP/SCCM 1992 definition) in the past year in two ICUs. Hydrocortisone was infused as suggested \[[@B2]\]. The time lapsing from start of vasopressors until start of hydrocortisone was determined by the patients\' charts.

Results
=======

Early start of hydrocortisone was determined by the quartiles of lapsing time as less than 24 hours. The impact of early start is shown in Figure [1](#F1){ref-type="fig"}. The mean APACHE II score for patients in early start was 22.09 and for patients in late start was 18.33 (*P =*NS). Cox regression analysis revealed that the only factor affecting final outcome was early start of hydrocortisone (HR: 4.85, 95% CI: 1.11 to 21.22, *P*= 0.036) as opposed to appropriateness of antimicrobial treatment (HR: 2.80, 95% CI: 0.56 to 13.91, *P =*NS).

![**Survival in relation to start of hydrocortisone**.](cc9832-1){#F1}

Conclusions
===========

Despite the observational approach, early start of hydrocortisone replacement in septic shock is a critical factor for outcome.
